← Leaderboards
Ami Siddharth Bhatt
Dana-Farber Cancer Inst
$7,172,945
Attributed
$8,842,766
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.7M · FY2014–25$10M$7.5M$5M$2.5M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,242,765 · 7
By mechanism
R01$7,637,578 · 4
U54$5,081,171 · 2
K08$524,016 · 1
Top collaborators
- Michael C Bassik1 shared
- Leslie S Kean1 shared
- Christopher Edward Mason1 shared
- Miguel-Angel Perales1 shared
- Michael P Snyder1 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Wendy Beth London$3,510,688
Others in their field
Top investigators on “Innovation”
- David R. Weir · University Of Michigan At Ann Arbor$382,307,654
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$319,874,172
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$311,654,401
- Richard A Gibbs · Baylor College Of Medicine$300,634,418
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$271,752,220
Research focus
InnovationPathogenInfectionOrganismAntibioticsIn VitroGenomicsSamplingMicrobialMicrobiomeLinkLaboratoriesComputing MethodologiesMultidisciplinaryComplementMethodologyFecesCohortEscherichia ColiGeneticBacteriaClinical MicrobiologyEmerging Antibiotic ResistanceGenome
Grant awards (17)
VAST Center: Viromes Across Space(s) and Time$4,399,999
U54 · FY2025 · AG
Optimizing HCT Outcomes: A Multi-omic Investigation$2,024,340
R01 · FY2025 · HL
VAST Center: Viromes Across Space(s) and Time$681,172
U54 · FY2025 · AG · contact PI
Mining the microbiome for immunomodulatory microproteins$640,522
R01 · FY2025 · CA · contact PI
Culture-free pathogen tracking in hospitalized patients$752,641
R01 · FY2023 · AI · contact PI
Emerging novel mechanisms of antibiotic resistance in the prevalent foodborne pathogen, Salmonella$394,250
R01 · FY2023 · AI · contact PI
Culture-free pathogen tracking in hospitalized patients$752,641
R01 · FY2022 · AI · contact PI
Emerging novel mechanisms of antibiotic resistance in the prevalent foodborne pathogen, Salmonella$394,250
R01 · FY2022 · AI · contact PI
Culture-free pathogen tracking in hospitalized patients$739,804
R01 · FY2021 · AI · contact PI
Emerging novel mechanisms of antibiotic resistance in the prevalent foodborne pathogen, Salmonella$394,250
R01 · FY2021 · AI · contact PI
Culture-free pathogen tracking in hospitalized patients$756,380
R01 · FY2020 · AI · contact PI
Emerging novel mechanisms of antibiotic resistance in the prevalent foodborne pathogen, Salmonella$394,250
R01 · FY2020 · AI · contact PI
Emerging novel mechanisms of antibiotic resistance in the prevalent foodborne pathogen, Salmonella$394,250
R01 · FY2019 · AI · contact PI
Sequence-based pathogen discovery in post-stem cell transplantation syndromes$173,448
K08 · FY2017 · CA · contact PI
Sequence-based pathogen discovery in post-stem cell transplantation syndromes$173,448
K08 · FY2016 · CA · contact PI
Sequence-based pathogen discovery in post-stem cell transplantation syndromes$173,448
K08 · FY2014 · CA · contact PI
Sequence-based pathogen discovery in post-stem cell transplantation syndromes$3,672
K08 · FY2014 · CA · contact PI